Effective and Affordable Flu Vaccines for the World

Información del proyecto

INDIGO

Identificador del acuerdo de subvención: 874653

DOI 10.3030/874653

Fecha de la firma de la CE 13 Diciembre 2019

Fecha de inicio 1 Abril 2020

Fecha de finalización 31 Marzo 2025

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total € 16 000 968,00

Aportación de la UE € 9 975 979,00

Coordinado por

STICHTING AMSTERDAM UMC
Netherlands

Resultado final

Documents, reports (2)

Report/Publication protective immunity TETRA-LITE in ferrets

ReportPublication protective immunity TETRALITE in ferrets

Report/Publication mode of action LVA for CTA

ReportPublication mode of action LVA for CTA

Websites, patent fillings, videos etc. (1)

Website, Facebook, etc.

Website Facebook etc

Publicaciones

Peer reviewed articles (2)

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells

Autores: Srinivasa Reddy Bonam, Peter Paul Platenburg and Jagadeesh Bayry
Publicado en: Frontiers Immunology, Edición 9 January 2023, 2023, ISSN 1664-3224
Editor: Frontiers in immunology

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

Autores: Sneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed andSweety Samal
Publicado en: Vaccines, Edición 31 March 2023, 2023, ISSN 2076-393X
Editor: Multidisciplinary Digital Publishing Institute (MDPI)